Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Bright Minds Biosciences Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 31 | 34 | +3 |
| Shares | 4.90M | 5.22M | +320.4K (+6.5%) |
| Value | $176.4M | $188.4M | +$12.0M (+6.8%) |
New holders (10)
Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Platinum Investment Management Ltd | 28,308 | $1.02M | 0.06% |
| Goldman Sachs Group Inc | 22,222 | $801.5K | 0.00% |
| Marshall Wace, LLP | 18,756 | $676.5K | 0.00% |
| Omers Administration Corp | 14,000 | $505.0K | 0.00% |
| HRT Financial LP | 13,568 | $489.0K | 0.00% |
| Citadel Advisors LLC | 6,885 | $248.3K | 0.00% |
| UBS Oconnor LLC | 5,963 | $215.1K | 0.01% |
| BNP Paribas Arbitrage, SA | 1,100 | $39.7K | 0.00% |
| Caitong International Asset Management Co., Ltd | 140 | $5.05K | 0.00% |
| JPMorgan Chase & Co | 300 | $2.39K | 0.00% |
Sold out (7)
Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Logos Global Management LP | 245,000 | $8.82M |
| Springhill Fund Asset Management (HK) Co Ltd | 60,648 | $2.18M |
| Atika Capital Management LLC | 15,000 | $540.3K |
| Advisor Group Holdings, Inc. | 175 | $6.30K |
| National Bank of Canada | 92 | $3.31K |
| US Bancorp | 26 | $937 |
| R Squared Ltd | 10 | $360 |